vcfirmsdirectory.com

Venture capital · Growth stage

BioVentures MedTech Funds

BioVentures MedTech Funds is a Massachusetts-based investment firm dedicated solely to medical technology companies, backing both early-stage and growth-stage businesses.

WestboroughRegistered · Westborough
New investments · 12 months
Fund vehiclesPublic
6
6 active · US private fund
First chequePublic
$15M–$100M
From the firm’s website
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:09 CETSources: bioventuresinvestors.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round BioVentures MedTech Funds joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is BioVentures MedTech Funds right for your round?

Is BioVentures MedTech Funds a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
6
6 active · US private fund
SEC adviser filings
First chequePublic
$15M–$100M
From the firm’s website
bioventuresinvestors.com
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL LPUS private fund · Active · United States · $206.9M gross assets · filed 26 Mar 2026
BIOVENTURES INVESTORS (OFFSHORE) IV LIMITED PARTNERSHIPUS private fund · Active · British Virgin Islands · $45.1M gross assets · filed 26 Mar 2026
BIOVENTURES INVESTORS IV LIMITED PARTNERSHIPUS private fund · Active · United States · $27.3M gross assets · filed 26 Mar 2026
BIOVENTURES INVESTORS III LIMITED PARTNERSHIPUS private fund · Active · United States · $13.3M gross assets · filed 26 Mar 2026
BIOVENTURES INVESTORS LIMITED PARTNERSHIP IIUS private fund · Active · United States · $7.6M gross assets · filed 26 Mar 2026
BIOVENTURES INVESTORS (OFFSHORE) III LPUS private fund · Active · British Virgin Islands · $2.6M gross assets · filed 26 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

Rounds BioVentures MedTech Funds joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round BioVentures MedTech Funds joined

Round sizes, BioVentures MedTech Funds’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

OptivioBrainbox SolutionsCareSignalCoNextionsDeep Vein Medical Inc.EndotronixInSealSono MotionUID Identification SolutionsVerax Biomedical

Portfolio and exits

Every company BioVentures MedTech Funds backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where BioVentures MedTech Funds puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet BioVentures MedTech Funds

Events where BioVentures MedTech Funds’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet BioVentures MedTech Funds’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

26 Mar 2026Fund filingForm ADV filed by BIOVENTURES INVESTORS: 6 private funds, $302.6M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

BioVentures MedTech Funds is based in Westborough, United States.

6 fund vehicles are on public registers (SEC adviser filings), including BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL LP, BIOVENTURES INVESTORS (OFFSHORE) IV LIMITED PARTNERSHIP and BIOVENTURES INVESTORS IV LIMITED PARTNERSHIP.

Stages: Growth. Sectors: Medtech. From the firm’s own website.

The firm believes technology is key to better healthcare and targets MedTech innovations that benefit patients, providers and payers, help contain rising healthcare costs, and appeal to likely acquirers. It provides capital, guidance and hands-on support to build company value through to exit. From the firm’s own website.

$15M to $100M per investment, according to the firm’s own website.

BioVentures MedTech Funds lists 10 portfolio companies on its website, including Optivio, Brainbox Solutions, CareSignal, CoNextions and Deep Vein Medical Inc..

Firms whose websites list some of the same companies include Aperture Venture Partners, BOLD Capital Partners and Dreamit Ventures.

Know before BioVentures MedTech Funds’s next round is announced.

PRO tracks BioVentures MedTech Funds’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

BioVentures MedTech FundsGet BioVentures MedTech Funds’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.